A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Van Nueten L.
Am J Psychiatry. 2016 Aug 1;173(8):816-26. doi: 10.1176/appi.ajp.2016.16010037.
Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.
Isitt JJ, Nadipelli VR, Kouassi A, Fava M, Heidbreder C.
Schizophr Res. 2016 Jul;174(1-3):126-31. doi: 10.1016/j.schres.2016.03.020.
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Am J Psychiatry.
Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH.
2016 Jun 1;173(6):575-87. doi: 10.1176/appi.ajp.2016.15091228. Epub 2016 Apr 26. Review.
Current Trends in Identifying Rapidly Acting Treatments for Depression Curr Behav Neurosci Rep.
Ionescu DF, Papakostas GI.
2016 Jun;3(2):185-191. Epub 2016 Apr 15.
Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice.
Petryshen TL, Lewis MC, Dennehy KA, Garza JC, Fava M.
Neurosci Lett. 2016 May 4;620:70-3. doi: 10.1016/j.neulet.2016.03.051.
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E.
Am J Psychiatry. 2016 May 1;173(5):499-508.
Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI, Martinson MA, Fava M, Iovieno N.
J Clin Psychiatry. 2016 May;77(5):e619-24. doi: 10.4088/JCP.14r09767.
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.
Nasser AF, Henderson DC, Fava M, Fudala PJ, Twumasi-Ankrah P, Kouassi A, Heidbreder C.
J Clin Psychopharmacol. 2016 Apr;36(2):130-140.
Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
Freeman MP, Fava M, Gommoll C, Chen C, Greenberg WM, Ruth A.
Int Clin Psychopharmacol. 2016 Mar;31(2):100-9.
Relationship between placebo response rate and clinical trial outcome in bipolar depression.
Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI.
J Psychiatr Res. 2016 Mar;74:38-44. doi: 10.1016/j.jpsychires.2015.12.016. Epub 2015 Dec 20.
© 2024 Copyright MGH Clinical Trials Network and Institute.
Website design by Tomo360